Frederick Palm

3.1k total citations
36 papers, 1.0k citations indexed

About

Frederick Palm is a scholar working on Epidemiology, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Frederick Palm has authored 36 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 9 papers in Neurology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Frederick Palm's work include Acute Ischemic Stroke Management (16 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Frederick Palm is often cited by papers focused on Acute Ischemic Stroke Management (16 papers), Atherosclerosis and Cardiovascular Diseases (5 papers) and Neuroinflammation and Neurodegeneration Mechanisms (5 papers). Frederick Palm collaborates with scholars based in Germany, Finland and United States. Frederick Palm's co-authors include Armin Grau, Christian Urbanek, Anton Safer, Heiko Becher, Florian Buggle, G. Inselmann, Johannes C. Wöhrle, Joachim Wolf, Michael G. Hennerici and Matthias Maschke and has published in prestigious journals such as PLoS ONE, Neurology and Stroke.

In The Last Decade

Frederick Palm

34 papers receiving 991 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick Palm Germany 17 459 348 181 152 132 36 1.0k
Carlos Cantú‐Brito Mexico 20 348 0.8× 409 1.2× 125 0.7× 190 1.3× 187 1.4× 121 1.2k
Emmanuel Charbonney Canada 21 280 0.6× 111 0.3× 244 1.3× 409 2.7× 117 0.9× 78 1.4k
Ahmed Elmaraezy Egypt 15 69 0.2× 90 0.3× 68 0.4× 83 0.5× 73 0.6× 21 815
Sami P. Moubayed Canada 21 113 0.2× 87 0.3× 74 0.4× 190 1.3× 43 0.3× 91 1.4k
Teresa Giani Italy 21 122 0.3× 56 0.2× 287 1.6× 163 1.1× 45 0.3× 84 1.1k
Robert M. Rennebohm United States 28 728 1.6× 161 0.5× 352 1.9× 499 3.3× 42 0.3× 55 2.3k
Laura Z. Fenton United States 23 300 0.7× 260 0.7× 360 2.0× 136 0.9× 26 0.2× 55 1.4k
Katharine A. Price United States 18 164 0.4× 55 0.2× 133 0.7× 372 2.4× 57 0.4× 77 1.4k
Ömer Nurı Pamuk Türkiye 25 248 0.5× 42 0.1× 305 1.7× 373 2.5× 68 0.5× 116 2.0k
A R Rosenthal United Kingdom 29 326 0.7× 175 0.5× 340 1.9× 96 0.6× 19 0.1× 81 2.5k

Countries citing papers authored by Frederick Palm

Since Specialization
Citations

This map shows the geographic impact of Frederick Palm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick Palm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick Palm more than expected).

Fields of papers citing papers by Frederick Palm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick Palm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick Palm. The network helps show where Frederick Palm may publish in the future.

Co-authorship network of co-authors of Frederick Palm

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick Palm. A scholar is included among the top collaborators of Frederick Palm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick Palm. Frederick Palm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hohenstein, Sven, et al.. (2025). How the COVID-19 Pandemic Impacted Neurological Hospital Admissions in Germany: A Retrospective Analysis. Neuroepidemiology. 60(1). 157–166.
2.
Dengler, Julius, Konstantin Prass, Frederick Palm, et al.. (2022). Changes in nationwide in-hospital stroke care during the first four waves of COVID-19 in Germany. European Stroke Journal. 7(2). 166–174. 10 indexed citations
3.
Pietiäinen, Milla, Anton Safer, Markku Lehto, et al.. (2020). Serum lipopolysaccharide neutralizing capacity in ischemic stroke. PLoS ONE. 15(2). e0228806–e0228806. 12 indexed citations
4.
Pietiäinen, Milla, Anton Safer, Markku Lehto, et al.. (2020). Serum lipopolysaccharide neutralizing capacity in ischemic stroke. STM:n Hallinnonalan avoin julkaisuarkisto (Julkari). 1 indexed citations
5.
Ozga, Ann‐Kathrin, Bernhard Rauch, Frederick Palm, et al.. (2020). Reevaluation of risk factors for time to subsequent events after first stroke occurrence using a new weighted all-cause effect measure. BMC Public Health. 20(1). 817–817. 2 indexed citations
6.
Palm, Frederick, Annette Aigner, Pirkko J. Pussinen, et al.. (2020). Association of a Multigenetic Pro-Inflammatory Profile with Ischaemic Stroke. Cerebrovascular Diseases. 49(2). 170–176. 10 indexed citations
7.
Ostheimer, C., et al.. (2019). Mortality after radiotherapy or surgery in the treatment of early stage non-small-cell lung cancer: a population-based study on recent developments. Journal of Cancer Research and Clinical Oncology. 145(11). 2813–2822. 12 indexed citations
8.
Urbanek, Christian, Anton Safer, Heiko Becher, et al.. (2018). Low self-reported sports activity before stroke predicts poor one-year-functional outcome after first-ever ischemic stroke in a population-based stroke register. BMC Neurology. 18(1). 181–181. 9 indexed citations
9.
Wolf, J., Anton Safer, Johannes C. Wöhrle, et al.. (2017). Todesursachen bei amyotropher Lateralsklerose. Der Nervenarzt. 88(8). 911–918. 16 indexed citations
10.
Purrucker, Jan, Kirsten Haas, Marcel Wolf, et al.. (2017). Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants. Journal of Stroke. 19(1). 67–76. 9 indexed citations
11.
Helms, Thomas M., Sigmund Silber, Andreas Schäfer, et al.. (2016). Konsensuspapier: Schlaganfallprophylaxe bei Patienten mit nichtvalvulärem Vorhofflimmern. Herzschrittmachertherapie + Elektrophysiologie. 27(3). 295–306. 3 indexed citations
12.
13.
Urbanek, Christian, Frederick Palm, Florian Buggle, et al.. (2014). Recent Surgery or Invasive Procedures and the Risk of Stroke. Cerebrovascular Diseases. 38(5). 370–376. 7 indexed citations
14.
Wolf, Joachim, Anton Safer, Johannes C. Wöhrle, et al.. (2014). Variability and prognostic relevance of different phenotypes in amyotrophic lateral sclerosis — Data from a population-based registry. Journal of the Neurological Sciences. 345(1-2). 164–167. 25 indexed citations
15.
Palm, Frederick, Nicholas Henschke, J. Wolf, et al.. (2013). Intracerebral haemorrhage in a population-based stroke registry (LuSSt): incidence, aetiology, functional outcome and mortality. Journal of Neurology. 260(10). 2541–2550. 40 indexed citations
16.
Palm, Frederick, et al.. (2013). Stroke seasonality associations with subtype, etiology and laboratory results in the Ludwigshafen Stroke Study (LuSSt). European Journal of Epidemiology. 28(5). 373–381. 52 indexed citations
17.
Palm, Frederick, Christian Urbanek, J. Wolf, et al.. (2011). Etiology, Risk Factors and Sex Differences in Ischemic Stroke in the Ludwigshafen Stroke Study, a Population-Based Stroke Registry. Cerebrovascular Diseases. 33(1). 69–75. 94 indexed citations
18.
Grau, Armin, Christian Urbanek, & Frederick Palm. (2010). Common infections and the risk of stroke. Nature Reviews Neurology. 6(12). 681–694. 145 indexed citations
19.
Urbanek, Christian, Frederick Palm, & Armin Grau. (2010). Influenza and Stroke Risk: A Key Target Not to be Missed?. Infectious Disorders - Drug Targets. 10(2). 122–131. 14 indexed citations
20.
Palm, Frederick, Christian Urbanek, & Armin Grau. (2009). Infection, its Treatment and the Risk for Stroke. Current Vascular Pharmacology. 7(2). 146–152. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carlos Cantú‐Brito Breakdown of academic impact, for papers by Emmanuel Charbonney Breakdown of academic impact, for papers by Ahmed Elmaraezy Breakdown of academic impact, for papers by Sami P. Moubayed Breakdown of academic impact, for papers by Teresa Giani Breakdown of academic impact, for papers by Robert M. Rennebohm Breakdown of academic impact, for papers by Laura Z. Fenton Breakdown of academic impact, for papers by Katharine A. Price Breakdown of academic impact, for papers by Ömer Nurı Pamuk Breakdown of academic impact, for papers by A R Rosenthal
Rankless by CCL
2026